Skip to main content
. Author manuscript; available in PMC: 2015 Nov 14.
Published in final edited form as: Cell Signal. 2014 Jan 22;26(5):959–967. doi: 10.1016/j.cellsig.2014.01.013

Fig. 8.

Fig. 8

Treatment with DNMT inhibitor led to a decreased GATAD1 3 [prime] DNA methylation and decreased GATAD1 expression. JAR cells were treated for 5 days with 0, 0.5, and 2.5 μM of 5-aza-deoxycytidine (ADC). a GATAD1 3 [prime] methylation was examined with COBRA. b Densitometry analyses indicated a dose-dependent decrease of GATAD1 3 [prime] DNA methylation following ADC treatment. c Results of real-time PCR showed a decrease of GATAD1 mRNA expression following ADC treatment. Data were standardized with the results from β-actin. Averages and standard errors were presented in the chart. **p < 0.01.